Abcellera Biologics Inc
NASDAQ:ABCL
Abcellera Biologics Inc
NASDAQ:ABCL
Price:
3.27
USD
-2.39%
Market Closed
Market Cap:
$991.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Abcellera Biologics Inc
NASDAQ:ABCL
|
CA |
|
Italmobiliare SpA
MIL:ITM
|
IT |
|
R
|
Reem Capital Corp
XTSX:REEM.P
|
CA |
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
CN |
|
Orion Group Holdings Inc
NYSE:ORN
|
US |
|
Qoria Ltd
ASX:QOR
|
AU |
|
Keerti Knowledge and Skills Ltd
NSE:KEERTI
|
IN |
|
Kellogg Co
NYSE:K
|
US |
|
Aurum Proptech Ltd
NSE:AURUM
|
IN |
|
M
|
Migdal Insurance and Financial Holdings Ltd
TASE:MGDL
|
IL |
|
H
|
Hugo Boss AG
OTC:HUGPF
|
DE |
|
DCI Indonesia Tbk PT
IDX:DCII
|
ID |
|
Westlake Corp
NYSE:WLK
|
US |
|
Dynavision Ltd
BSE:517238
|
IN |
|
P
|
PetroVietnam Power Nhon Trach 2 JSC
VN:NT2
|
VN |
|
G
|
Grupo Financiero Multiva SAB de CV
BMV:GFMULTIO
|
MX |
|
ANTA Sports Products Ltd
HKEX:2020
|
CN |
|
Autoliv Inc
F:LIV
|
US |
|
Electromedical Technologies Inc
OTC:EMED
|
US |
|
Wall Financial Corp
TSX:WFC
|
CA |
|
I
|
INC SA
WSE:INC
|
PL |
|
P
|
Paysauce Ltd
NZX:PYS
|
NZ |
|
CNS Pharmaceuticals Inc
NASDAQ:CNSP
|
US |
|
Sino Hotels (Holdings) Ltd
HKEX:1221
|
HK |
Multiples-Based Value
The Multiples-Based Value of one
ABCL
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 3.27 USD,
Abcellera Biologics Inc
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ABCL Multiples-Based Value
LOCKED
Multiples Across Competitors
ABCL Competitors Multiples
Abcellera Biologics Inc Competitors
Abcellera Biologics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
|
Abcellera Biologics Inc
NASDAQ:ABCL
|
983m USD | 13.1 | -6.7 | -2.4 | -2.1 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
965.3B USD | 338 | 4 002.1 | 1 146.8 | 2 208.3 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
178.1B USD | 4 | 26.6 | 18.5 | 24.9 | |
| US |
|
Danaher Corp
NYSE:DHR
|
128.3B USD | 5.2 | 35.5 | 18.2 | 26.4 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 18.1 | 46.1 | 30.1 | 39.4 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
33.9B CHF | 5.1 | 35.3 | 26.3 | 26.3 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
289.4B CNY | 6.3 | 15 | 15.6 | 15.6 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
31.2B USD | 4.4 | 24.2 | 17.8 | 21 | |
| US |
|
Waters Corp
NYSE:WAT
|
28.4B USD | 9 | 44.1 | 28.5 | 35.8 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
27.8B USD | 1.7 | 20.5 | 11.6 | 17.3 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
25.1B USD | 6.2 | 28.9 | 21.5 | 23.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
